Significantly lower prandial glucose increment with NovoMix® 30
{"Image DocumentName": "Significantly lower prandial glucose increment with NovoMix\u00ae 30", "Image ImageDescription": "p < 0.02 between treatment groups. (mmol/l) Mean prandial glucose increment. ANA 038. Summary: At 12 weeks, mean prandial glucose excursion was significantly less (p < 0.02) in the NovoMix 30 group compared with the BHI 30 group. Postprandial glycaemic control was significantly better with NovoMix\u00ae 30 when analysed on the basis of mean prandial blood glucose increment - mean increment (post-meal minus pre-meal blood glucose) over the three meals including lunch, when no insulin was given. After 12 weeks, mean prandial glucose increment was 1.66 \u00b1 0.20 mmol/l in the NovoMix\u00ae 30 group versus 2.34 \u00b1 0.19 mmol/l for BHI 30 (p < 0.02). After three months treatment, levels of HbA1c did not differ between the two treatment groups. Only subjects who had a complete set of values for each of the 8-point blood glucose time points were included in the analysis. NovoMix\u00ae 30. BHI 30. (n = 128) (n = 141) Boehm B et al. Diabet Med 2002;19(5):393\u2013399.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}